Loading

Panel: Navigating reimbursement and market access for cell and gene therapies

04 Sep 2025

12:45 - 13:15

Theatre 2

Manufacturing, scale up & commercial strategy

Explore strategies for securing reimbursement and market access for cell and gene therapies, focusing on pricing, HTAs, and policy advocacy to ensure patient access.

Chairperson

Michela Gabaldo, Vice President, ATMP Global Regulatory Affairs - Evotec

Speakers

Hector De la Riva, National Healthcare System Partnership Manager - Novartis

Lydia Shotton, Associate Director EU Government Affairs - Alliance for Regenerative Medicine

Oresta Piniazhko, Director of HTA Department - The State Expert Center of the Ministry of Health of Ukraine